In this randomized , double-blind , non-inferiority , active-controlled study , adult subjects with CKD-ND , Hb levels < @g/dL , and not treated with an erythropoiesis-stimulating agent were randomized @:@ to receive DA every @ weeks ( Q@W ) or QM for @ weeks with initial doses of @ g/kg Q@W or @ g/kg QM .